Abalone Bio is an early stage biotech start-up that develops antibody drugs for the treatment of diseases. The company uses libraries of yeast cells expressing billions of antibody variants to grow specific antibodies that can activate or inhibit a drug target, and also uses gene sequencing, machine learning, and synthetic biology to make recombinant protein versions of its antibodies and confirm their efficacy in human cell assays, allowing treatment of rare diseases with unique modes of action. Abalone Bio was founded in 2017 and is headquartered in Richmond, California.

San Francisco, CA, USA

Join TechBio Companies Driving Patient Impact